The role of oxidative stress in glaucoma

被引:446
作者
Izzotti, A
Bagnis, A
Saccà, SC
机构
[1] Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy
[3] San Martino Hosp, Sect Ophthalmol, I-16132 Genoa, Italy
关键词
primary open angle glaucoma; oxidative stress; genetic susceptibility; glaucoma prevention;
D O I
10.1016/j.mrrev.2005.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
DNA damage is related to a variety of degenerative diseases such as cancer, atherosclerosis and neurodegenerative diseases, depending on the tissue affected. Increasing evidence indicates that reactive oxygen species (ROS) play a key role in the pathogenesis of primary open angle glaucoma (POAG), the main cause of irreversible blindness worldwide. Oxidative DNA damage is significantly increased in the ocular epithelium regulating aqueous humor outflow, i.e., the trabecular meshwork (TM), of glaucomatous patients compared to controls. The pathogenic role of ROS in glaucoma is supported by various experimental findings, including (a) resistance to aqueous humor outflow is increased by hydrogen peroxide by inducing TM degeneration; (b) TM possesses remarkable antioxidant activities, mainly related to superoxide dismutase-catalase and glutathione pathways that are altered in glaucoma patients; and (c) intraocular-pressure increase and severity of visual-field defects in glaucoma patients parallel the amount of oxidative DNA damage affecting TM. Vascular alterations, which are often associated with glaucoma, could contribute to the generation of oxidative damage. Oxidative stress, occurring not only in TM but also in retinal cells, appears to be involved in the neuronal cell death affecting the optic nerve in POAG. The highlighting of the pathogenic role of ROS in POAG has implications for the prevention of this disease as indicated by the growing number of studies using genetic analyses to identify susceptible individuals and of clinical trials testing the efficacy of antioxidant drugs for POAG management. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 95 条
[1]
Abreu RMV, 2000, J PHARMACOL EXP THER, V295, P1022
[2]
ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714
[3]
ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564
[4]
Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLCIA) [J].
Alward, WLM ;
Fingert, JH ;
Coote, MA ;
Johnson, AT ;
Lerner, SF ;
Junqua, D ;
Durcan, FJ ;
McCartney, PJ ;
Mackey, DA ;
Sheffield, VC ;
Stone, EM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (15) :1022-1027
[5]
Reperfusion injury: Experimental evidence and clinical implications [J].
Ambrosio, G ;
Tritto, I .
AMERICAN HEART JOURNAL, 1999, 138 (02) :S69-S75
[6]
[Anonymous], ABSORPTION UTILIZATI
[7]
BARKSDALE S, 1986, Investigative Ophthalmology and Visual Science, V27, P210
[8]
Brubaker RF, 2000, INVEST OPHTH VIS SCI, V41, P1681
[9]
Budde W M, 2000, Curr Opin Ophthalmol, V11, P101, DOI 10.1097/00055735-200004000-00006
[10]
Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells [J].
Caballero, M ;
Liton, PB ;
Epstein, DL ;
Gonzalez, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :346-352